1. Hall RCW, Zisook S. Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol. 1981;11:99S-104S.
2.
2. Van der Bijl, Roeslofse JA. Disinhibitory reactions to benzodiazepines: a review. J Oral Maxillofac Surg. 1991;49:519-523.
3.
3. Seneff MG, Mathews RA. Use of haloperidol infusions to control delirium in critically ill adults. Ann Pharmacother1995;29:690-693.
4.
4. Froemming JS, Lam YWF, Jann MW, Davis CM. Pharmacokinetics of haloperidol. Clin Pharmacokinet. 1989; 17:396-423.
5.
5. Beresford R, Ward A. Haloperidol decanoate. Drugs. 1987;33:31-49.
6.
6. Bair N, Bobek MB, Hoffman-Hogg L, et al. Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit: physician and nurse adherence. Crit Care Med2000;28:707-713.
7.
7. Harvey MA. Managing agitation in critically ill adults. Am J Crit Care. 1996; 5:7-16.
8.
8. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. JAMA. 1991;266:2870-2875.
9.
9. Adams F. Emergency intravenous sedation of the delirious, medically ill patient. J Clin Psychiatry. 1988;49:22-26.
10.
10. Fernandez F, Holmes VF, Adams F, Kavanaugh JJ. Treatment of severe, refractory agitation with a haloperidol drip. J Clin Psychiatry. 1988;49:239-241.
11.
11. Riker RR, Fraser GL, Cox PM. Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med1994;22:433-440.
12.
12. Fish DN. Treatment of delirium in the critically ill patient. Clin Pharm1991; 10:456-466.
13.
13. Menza MA, Murray GB, Holmes VF, Rafuls WA. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung. 1988;17:238-241.
15. Tesar GE, Murray GB, Cassem NH. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol. 1985;5:344-347.
